Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial
- Posted on September 8, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial
Sept 8 (Reuters) - Bristol Myers Squibb said on Tuesday its experimental cell therapy for a type of blood cancer had met the main goal of a mid-stage trial. The company was testing the therapy, called arlocabtagene autoleucel, or arlo-cel, in patients with a hard-to-treat form of multiple myeloma, a type of blood cancer. The study met its main goal, showing significant improvement in the
